Evaluation of the Vysis IntelliFISH Hybridization Buffer and Vysis IntelliFISH Universal FFPE Pretreatment and Wash Kit in FISH Assays

Jiawei Zhao, MS


Standard fluorescence in-situ hybridization (FISH) technique requires a hybridization time of 12 hours or greater, thus amounting to a turn-around time (TAT) of 24 hours or greater for result reporting. To improve the TAT for the FISH tests, a new Vysis IntelliFISH Hybridization Buffer has been recently developed by Abbott Molecular. It was evaluated in 20 pairs of matched bone marrow samples and 10 pairs of matched formalin-fixed lymphoma tissue samples against the standard Vysis LSI/WCP Hybridization Buffer protocol. Compared to the standard Vysis LSI/WCP Hybridization Buffer protocol, the new fast working Vysis IntelliFISH Hybridization Buffer protocol reduced FISH hybridization time and simplified the workflow of the standard overnight hybridization protocol. In addition, signal intensity, slide background and signal specificity of FISH probes were comparable to those generated with the standard hybridization protocol.

[N A J Med Sci. 2017;10(1):5-7.   DOI:  10.7156/najms.2017.1001005]


fluorescence in situ hybridization assay, leukemia, lymphoma

Full Text:



Abel HJ, Al-Kateb H, Cottrell CE, et al. Detection of Gene Rearrangements in Targeted Clinical Next-Generation Sequencing. J Mol Diagn. 2014;16:405-417.

Sirvent N, Coindre JM, Maire G, et al. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am J Surg Pathol. 2007;31:1476-1489.

Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol. 2008;21:943-949.

Kearney L. The impact of the new FISH technologies on the cytogenetics of haematological malignancies. Br J Haematol. 1999;104:648-658.

Van der Burg M, Smit B, Brinkhof B, et al. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test. Leukemia. 2002;16:755-761.

Schoch C, Schnittger S, Bursch S, et al. Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases. Leukemia. 2002;16:53-59.

Schulz JE, Amin HD, Legator MS, et al. Evaluation of Universal FISH Pretreatment Reagents on Multiple Formalin-Fixed, Paraffin-Embedded Tissue Types [abstract]. In: Proceedings of the Association for Molecular Pathology 2015 Annual Meeting; 2015 Nov 5-7, Austin, Texas: AMP 2015. Abstract nr T32.

Wilber-Mader KA, Lucas M, Pestova K, et al. Performance of a New Vysis FISH Hybridization Buffer that Facilitates Single Day FISH Results. In: Proceedings of the Association for Molecular Pathology 2015 Annual Meeting; 2015 Nov 5-7, Austin, Texas: AMP 2015. Abstract nr T34.

Fang Xu, Peining Li. Developmental Disabilities - Molecules Involved, Diagnosis, and Clinical Care: Cytogenomic abnormalities and dosage-sensitive mechanisms for intellectual and developmental disabilities, 1st Edition. Edited by Ahmad Salehi (Rijeka: InTech):2013.

Hu L, Ru K, Zhang L, et al. Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine. Biomark Res. 2014;2:1-13.

Liehr T, Othman MA, K Rittscher, et al. The current state of molecular cytogenetics in cancer diagnosis. Expert Rev Mol Diagn. 2015;15:517-526.

Mikhail FM, Heerema NA, Rao KW, et al. Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities. Genet Med. 2016;18:635-642.


  • There are currently no refbacks.